C200-3740 Screening compound: 2-{8,9-dimethoxy-5-oxo-2-phenyl-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-6-yl}-N-phenylacetamide

C200-3740 Screening compound: 2-{8,9-dimethoxy-5-oxo-2-phenyl-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-6-yl}-N-phenylacetamide
C200-3740 Screening compound: 2-{8,9-dimethoxy-5-oxo-2-phenyl-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-6-yl}-N-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C200-3740
2-{8,9-dimethoxy-5-oxo-2-phenyl-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-6-yl}-N-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C200-3740

Molecular Formula

C25H21N5O4 (C25 H21 N5 O4)

Compound Name

2-{8,9-dimethoxy-5-oxo-2-phenyl-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-6-yl}-N-phenylacetamide

IUPAC name

2-{89-dimethoxy-5-oxo-2-phenyl-5H6H-[124]triazolo[15-c]quinazolin-6-yl}-N-phenylacetamide

SMILES

COc(c(OC)c1)cc(-c2nc(-c3ccccc3)nn22)c1N(CC(Nc1ccccc1)=O)C2=O

InChI

InChI=1S/C25H21N5O4/c1-33-20-13-18-19(14-21(20)34-2)29(15-22(31)26-17-11-7-4-8-12-17)25(32)30-24(18)27-23(28-30)16-9-5-3-6-10-16/h3-14H,15H2,1-2H3,(H,26,31)

InChI Key

OLWSSQDRTDQXPY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14727035

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.47

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.201

Distribution Coefficient, logD

4.201

Water Solubility, LogSw

-4.35

Polar Surface Area

77.505

Acid Dissociation Constant (pKa)

12.87

Base Dissociation Constant (pKb)

2.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.00

C200-3740 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Antiviral Library (67538 compounds)

Purinergic Library (3321 compounds)

Targeted Diversity Library (40567 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Cardiovascular
  • Metabolic
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C200-3740 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C200-3740?
Check Price and Availability of C200-3740, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C200-3740 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C200-3740
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C200-3740
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C200-3740 available by request